0000950142-19-001715.txt : 20190808 0000950142-19-001715.hdr.sgml : 20190808 20190807202606 ACCESSION NUMBER: 0000950142-19-001715 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190808 DATE AS OF CHANGE: 20190807 EFFECTIVENESS DATE: 20190808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aisling Capital LLC CENTRAL INDEX KEY: 0001571076 IRS NUMBER: 010849048 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15878 FILM NUMBER: 191007187 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6372 MAIL ADDRESS: STREET 1: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001571076 XXXXXXXX 06-30-2019 06-30-2019 false Aisling Capital LLC
888 Seventh Avenue, 12th Floor New York NY 10106
13F HOLDINGS REPORT 028-15878 N
Robert Wenzel Chief Financial Officer 212-651-6374 /s/ Robert Wenzel New York NY 08-07-2019 0 4 60338
INFORMATION TABLE 2 infotable.xml ADMA BIOLOGICS INC COM 000899104 13964 3608171 SH SOLE 3608171 0 0 AIMMUNE THERAPEUTICS INC. COM 00900T107 41432 1990000 SH SOLE 1990000 0 0 CIDARA THERAPEUTICS INC. COM 171757107 1716 1021148 SH SOLE 1021148 0 0 TRANSENTERIX INC. COM NEW 89366M201 3226 2389352 SH SOLE 2389352 0 0